Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac... Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmaceutical and biotechnology company based in China, Innovent is dedicated to advancing affordable and innovative medications. Its robust pipeline includes monoclonal antibodies and immunotherapy solutions, aiming to address the unmet medical needs globally. Innovent Biologics places significant emphasis on collaborative alliances with global partners to harness cutting-edge technologies and enhance its research capabilities. This asset plays a pivotal role in the healthcare and pharmaceutical sectors, offering potential advancements in treatment that could improve the quality of life for millions. The company's influence extends through its contribution to medical research and its potential impact on global health initiatives.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Innovent Biologics is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Innovent Biologics is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Innovent Biologics's data?

Start your 30-day free trial to request a data review for Innovent Biologics.

Start Free Trial

Legal Center Contact Us